| NDC Code | 43742-0944-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-0944-1) |
|---|
| Product NDC | 43742-0944 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Oratox |
|---|
| Non-Proprietary Name | Fucus Vesiculosus, Lymph Node (suis), Medulla Ossis Suis, Thymus (suis), Thyroidinum (suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20161227 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | CALCIUM CHLORIDE; COPPER; EUGENOL; FORMALDEHYDE; FUCUS VESICULOSUS; GOLD; IODINE; LIDOCAINE; MERCURIUS SOLUBILIS; MOLYBDENUM; NICKEL; PALLADIUM; SELENIUM; SILVER; SODIUM CHLORIDE; SODIUM FLUORIDE; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA THYMUS; THYROID; TIN; TITANIUM; VANADIUM; ZINC |
|---|
| Strength | 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 8; 8; 8; 12; 12; 12; 12 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Local Anesthesia [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC] |
|---|